|
G |
Asph |
aspartate beta-hydroxylase |
|
ISO |
mRNA:increased expression:bile duct |
RGD |
PMID:16673309 |
RGD:2325824 |
NCBI chrNW_004936496:11,604,992...11,815,680
Ensembl chrNW_004936496:11,604,680...11,816,852
|
|
G |
Egfr |
epidermal growth factor receptor |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:17341899 |
|
NCBI chrNW_004936678:365,005...560,546
Ensembl chrNW_004936678:365,834...436,528
|
|
G |
Fscn1 |
fascin actin-bundling protein 1 |
disease_progression |
ISO |
protein:increased expression:bile duct |
RGD |
PMID:17419223 |
RGD:2317786 |
NCBI chrNW_004936765:609,894...619,417
Ensembl chrNW_004936765:609,861...619,456
|
|
G |
Il6 |
interleukin 6 |
disease_progression |
ISO |
protein:increased expression:serum |
RGD |
PMID:17617204 |
RGD:2317166 |
NCBI chrNW_004936549:7,015,595...7,016,246
|
|
G |
Met |
MET proto-oncogene, receptor tyrosine kinase |
|
ISO |
protein:increased expression:intrahepatic bile duct (human) |
RGD |
PMID:15892172 |
RGD:2317585 |
NCBI chrNW_004936589:2,280,803...2,390,179
Ensembl chrNW_004936589:2,280,799...2,390,179
|
|
G |
Mgmt |
O-6-methylguanine-DNA methyltransferase |
severity |
ISO |
protein:decreased expression:carcinoma of extrahepatic bile duct (human) |
RGD |
PMID:11986189 |
RGD:2317662 |
NCBI chrNW_004936486:16,744,607...16,923,209
Ensembl chrNW_004936486:16,744,570...16,923,543
|
|
G |
Mki67 |
marker of proliferation Ki-67 |
disease_progression |
ISO |
|
RGD |
PMID:9869516 |
RGD:2317706 |
NCBI chrNW_004936486:15,561,327...15,587,109
|
|
G |
Muc16 |
mucin 16, cell surface associated |
|
ISO |
protein:increased expression:serum,bile |
RGD |
PMID:1657243 |
RGD:2325134 |
NCBI chrNW_004936588:5,506,683...5,586,450
|
|
G |
Muc4 |
mucin 4, cell surface associated |
disease_progression |
ISO |
protein:increased expression:bile duct |
RGD |
PMID:16857800 |
RGD:2324929 |
NCBI chrNW_004936784:515,608...539,915
|
|
G |
Ncam1 |
neural cell adhesion molecule 1 |
disease_progression |
ISO |
|
RGD |
PMID:8501910 PMID:9851639 |
RGD:2326076 RGD:2326077 |
NCBI chrNW_004936612:1,262,557...1,556,281
Ensembl chrNW_004936612:1,262,544...1,556,016
|
|
G |
Runx3 |
RUNX family transcription factor 3 |
|
ISO |
DNA:hypermethylation:promoter |
RGD |
PMID:15471559 |
RGD:2324957 |
NCBI chrNW_004936474:9,751,946...9,802,910
Ensembl chrNW_004936474:9,751,946...9,802,910
|
|
|
G |
Slc7a5 |
solute carrier family 7 member 5 |
disease_progression |
ISO |
|
RGD |
PMID:24131658 |
RGD:151361287 |
NCBI chrNW_004936641:1,513,110...1,538,955
|
|
|
G |
Braf |
B-Raf proto-oncogene, serine/threonine kinase |
|
ISO |
DNA:missense mutation:cds:p.V600E (human) |
RGD |
PMID:25704541 |
RGD:11521169 |
NCBI chrNW_004936592:4,728,371...4,833,830
Ensembl chrNW_004936592:4,737,011...4,834,664
|
|
|
G |
Apob |
apolipoprotein B |
susceptibility |
ISO |
DNA:polymorphisms:intron, exon:IVS6+360C>T, 56C>T (human) |
RGD |
PMID:18296645 |
RGD:2317550 |
NCBI chrNW_004936493:10,509,118...10,549,144
Ensembl chrNW_004936493:10,509,118...10,549,144
|
|
G |
Apoe |
apolipoprotein E |
susceptibility |
ISO |
DNA:SNP:intron:rs440446 (human) |
RGD |
PMID:18296645 |
RGD:2317550 |
NCBI chrNW_004936706:1,512,438...1,516,805
|
|
G |
Atm |
ATM serine/threonine kinase |
|
ISO |
ClinVar Annotator: match by term: Bile duct cancer |
ClinVar |
PMID:9887333 PMID:17124347 PMID:20077034 PMID:25741868 PMID:26635394 PMID:28492532 More...
|
|
NCBI chrNW_004936551:359,134...534,672
Ensembl chrNW_004936551:359,362...532,211
|
|
G |
Mlh1 |
mutL homolog 1 |
|
ISO |
ClinVar Annotator: match by term: Bile duct cancer |
ClinVar |
PMID:15340264 PMID:17510385 PMID:18307539 PMID:19419416 PMID:22136435 PMID:22703879 PMID:24033266 PMID:24728327 PMID:25741868 PMID:28492532 More...
|
|
NCBI chrNW_004936473:26,556,636...26,600,830
Ensembl chrNW_004936473:26,556,611...26,603,736
|
|
G |
Msh2 |
mutS homolog 2 |
|
ISO |
ClinVar Annotator: match by term: Bile duct cancer |
ClinVar |
PMID:25741868 PMID:33357406 |
|
NCBI chrNW_004936508:4,943,987...5,013,356
Ensembl chrNW_004936508:4,944,007...5,013,356
|
|
G |
Palb2 |
partner and localizer of BRCA2 |
|
ISO |
ClinVar Annotator: match by term: Bile duct cancer |
ClinVar |
PMID:25741868 PMID:26467025 PMID:28492532 PMID:30287823 |
|
NCBI chrNW_004936501:8,246,927...8,273,258
|
|
G |
Pkd1 |
polycystin 1, transient receptor potential channel interacting |
|
ISO |
ClinVar Annotator: match by term: Bile duct cancer |
ClinVar |
PMID:12007219 PMID:16430766 PMID:17574468 PMID:25741868 PMID:26467025 PMID:27782177 More...
|
|
NCBI chrNW_004936694:1,923,383...1,958,160
Ensembl chrNW_004936694:1,930,621...1,957,179
|
|
G |
Pold1 |
DNA polymerase delta 1, catalytic subunit |
|
ISO |
ClinVar Annotator: match by term: Bile duct cancer |
ClinVar |
PMID:25741868 PMID:26467025 PMID:28492532 |
|
NCBI chrNW_004936889:231,373...250,985
Ensembl chrNW_004936889:231,373...250,987 Ensembl chrNW_004936889:231,373...250,987
|
|
G |
Stk11 |
serine/threonine kinase 11 |
|
ISO |
ClinVar Annotator: match by term: Bile duct cancer |
ClinVar |
PMID:25741868 PMID:28492532 |
|
NCBI chrNW_004936588:579,816...601,033
Ensembl chrNW_004936588:579,816...603,654
|
|
G |
Tjp1 |
tight junction protein 1 |
|
ISO |
protein:decreased expression:bile duct |
RGD |
PMID:19184677 |
RGD:2325030 |
NCBI chrNW_004936483:1,814,870...2,045,802
Ensembl chrNW_004936483:1,814,894...2,030,946
|
|
|
G |
Slc7a5 |
solute carrier family 7 member 5 |
disease_progression |
ISO |
|
RGD |
PMID:24890221 |
RGD:151361210 |
NCBI chrNW_004936641:1,513,110...1,538,955
|
|
|
G |
Abcc2 |
ATP binding cassette subfamily C member 2 |
susceptibility |
ISO |
DNA:polymorphism:exon:c.3972C>T (human) |
RGD |
PMID:19451719 |
RGD:2317508 |
NCBI chrNW_004936636:292,631...341,999
Ensembl chrNW_004936636:292,709...340,393
|
|
G |
Adrb2 |
adrenoceptor beta 2 |
|
ISO |
protein:decreased expression:liver |
RGD |
PMID:16292515 |
RGD:2325640 |
NCBI chrNW_004936504:5,985,407...5,987,453
Ensembl chrNW_004936504:5,985,960...5,987,210
|
|
G |
Alox5 |
arachidonate 5-lipoxygenase |
|
ISO |
protein:increased expression:bile duct |
RGD |
PMID:18507031 |
RGD:2317521 |
NCBI chrNW_004936554:7,807,914...7,848,691
Ensembl chrNW_004936554:7,808,355...7,867,931
|
|
G |
Anxa2 |
annexin A2 |
disease_progression |
ISO |
|
RGD |
PMID:20493868 |
RGD:2325728 |
NCBI chrNW_004936471:21,274,112...21,329,286
Ensembl chrNW_004936471:21,274,027...21,329,503
|
|
G |
Apc |
APC regulator of WNT signaling pathway |
|
ISO |
DNA:loss of heterozygosity DNA:hypermethylation:promoter |
RGD |
PMID:10212000 PMID:15467712 |
RGD:2317198 RGD:2317205 |
NCBI chrNW_004936531:6,899,580...7,019,016
Ensembl chrNW_004936531:6,899,788...7,019,453
|
|
G |
Apoa1 |
apolipoprotein A1 |
|
ISO |
protein:decreased expression:serum |
RGD |
PMID:19486127 |
RGD:2325756 |
NCBI chrNW_004936542:2,111,055...2,112,626
Ensembl chrNW_004936542:2,111,052...2,112,854
|
|
G |
Arid1a |
AT-rich interaction domain 1A |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:24185509 |
|
NCBI chrNW_004936474:11,148,857...11,197,312
|
|
G |
Asph |
aspartate beta-hydroxylase |
|
ISO |
|
RGD |
PMID:21898484 |
RGD:6902945 |
NCBI chrNW_004936496:11,604,992...11,815,680
Ensembl chrNW_004936496:11,604,680...11,816,852
|
|
G |
Atg101 |
autophagy related 101 |
disease_progression |
ISO |
|
RGD |
PMID:35592424 |
RGD:153350091 |
NCBI chrNW_004936512:9,518,128...9,525,986
Ensembl chrNW_004936512:9,518,074...9,526,961
|
|
G |
Bap1 |
BRCA1 associated deubiquitinase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:24185509 PMID:25231345 |
|
NCBI chrNW_004936473:3,239,009...3,247,806
Ensembl chrNW_004936473:3,239,010...3,247,806
|
|
G |
Birc6 |
baculoviral IAP repeat containing 6 |
ameliorates |
ISO |
mRNA:increased expression:bile duct (human) |
RGD |
PMID:31964418 |
RGD:153344516 |
NCBI chrNW_004936493:903,295...1,115,434
Ensembl chrNW_004936493:899,961...1,115,493
|
|
G |
Braf |
B-Raf proto-oncogene, serine/threonine kinase |
|
ISO |
DNA:missense mutation:cds:p.V600E (human) |
RGD |
PMID:12692057 |
RGD:11073239 |
NCBI chrNW_004936592:4,728,371...4,833,830
Ensembl chrNW_004936592:4,737,011...4,834,664
|
|
G |
Cxcr1 |
C-X-C motif chemokine receptor 1 |
|
ISO |
ClinVar Annotator: match by term: Cholangiocarcinoma |
ClinVar |
PMID:18550579 |
|
NCBI chrNW_004936569:715,129...716,187
Ensembl chrNW_004936569:715,129...716,181
|
|
G |
Egf |
epidermal growth factor |
|
ISO |
ClinVar Annotator: match by term: Cholangiocarcinoma |
ClinVar |
PMID:18550579 PMID:25741868 PMID:28492532 |
|
NCBI chrNW_004936563:1,058,803...1,181,393
|
|
G |
Egfr |
epidermal growth factor receptor |
|
ISO |
ClinVar Annotator: match by term: Cholangiocarcinoma |
ClinVar |
PMID:18550579 PMID:24728327 PMID:25741868 PMID:28492532 |
|
NCBI chrNW_004936678:365,005...560,546
Ensembl chrNW_004936678:365,834...436,528
|
|
G |
Epo |
erythropoietin |
|
ISO |
mRNA, protein:increased expression:liver |
RGD |
PMID:23052842 |
RGD:10400912 |
NCBI chrNW_004936543:742,722...745,332
Ensembl chrNW_004936543:743,537...745,343
|
|
G |
Epor |
erythropoietin receptor |
|
ISO |
mRNA, protein:increased expression:liver |
RGD |
PMID:23052842 |
RGD:10400912 |
NCBI chrNW_004936659:1,468,391...1,473,880
Ensembl chrNW_004936659:1,468,634...1,473,880
|
|
G |
Erbb2 |
erb-b2 receptor tyrosine kinase 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16818635 |
|
NCBI chrNW_004936490:14,887,062...14,910,038
Ensembl chrNW_004936490:14,887,043...14,909,956
|
|
G |
Ezh2 |
enhancer of zeste 2 polycomb repressive complex 2 subunit |
disease_progression no_association |
ISO |
DNA:SNP: :g.148505302C>T (rs887569) (human) DNA:SNPs: :g.148525904C>G, (rs2302427), g.148519011C>T (rs6464926), g.148517456T>G (rs17171119) (human) |
RGD |
PMID:24179546 |
RGD:126779604 |
NCBI chrNW_004936527:5,024,077...5,069,152
Ensembl chrNW_004936527:5,024,068...5,063,939
|
|
G |
Faslg |
Fas ligand |
|
ISO |
|
RGD |
PMID:11029528 |
RGD:2317746 |
NCBI chrNW_004936481:14,789,547...14,795,780
|
|
G |
Fgfr2 |
fibroblast growth factor receptor 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:26258846 |
|
NCBI chrNW_004936486:10,506,680...10,606,272
Ensembl chrNW_004936486:10,507,097...10,602,019
|
|
G |
Fscn1 |
fascin actin-bundling protein 1 |
disease_progression |
ISO |
protein:increased expression:bile ducts |
RGD |
PMID:19721413 |
RGD:2317780 |
NCBI chrNW_004936765:609,894...619,417
Ensembl chrNW_004936765:609,861...619,456
|
|
G |
Gstp1 |
glutathione S-transferase pi 1 |
treatment |
ISO |
human cell line in a mouse model DNA:hypermethylation:promoter |
RGD |
PMID:12805482 PMID:15467712 |
RGD:14401711 RGD:2317198 |
NCBI chrNW_004936599:2,197,681...2,200,642
Ensembl chrNW_004936599:2,197,634...2,201,050
|
|
G |
Hdac6 |
histone deacetylase 6 |
|
ISO |
protein:increased expression:liver: |
RGD |
PMID:23370327 |
RGD:9681560 |
NCBI chrNW_004936721:757,500...778,416
Ensembl chrNW_004936721:758,181...778,053
|
|
G |
Hgf |
hepatocyte growth factor |
|
ISO |
mRNA, protein:increased expression: : protein:increased expression:serum |
RGD |
PMID:10827151 PMID:16974053 |
RGD:2317909 RGD:2317925 |
NCBI chrNW_004936734:354,798...428,356
Ensembl chrNW_004936734:356,115...428,779
|
|
G |
Hif1a |
hypoxia inducible factor 1 subunit alpha |
|
ISO |
ClinVar Annotator: match by term: Cholangiocarcinoma |
ClinVar |
PMID:12919954 PMID:18550579 PMID:22647679 PMID:24120591 PMID:25741868 |
|
NCBI chrNW_004936495:5,770,988...5,816,157
Ensembl chrNW_004936495:5,770,669...5,816,157
|
|
G |
Idh1 |
isocitrate dehydrogenase (NADP(+)) 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:24185509 |
|
NCBI chrNW_004936950:334,894...349,221
Ensembl chrNW_004936950:334,934...348,363
|
|
G |
Idh2 |
isocitrate dehydrogenase (NADP(+)) 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:24185509 |
|
NCBI chrNW_004936483:15,845,777...15,864,341
Ensembl chrNW_004936483:15,845,792...15,864,341
|
|
G |
Il10 |
interleukin 10 |
|
ISO |
ClinVar Annotator: match by term: Cholangiocarcinoma |
ClinVar |
PMID:11121048 PMID:14657422 PMID:14657427 PMID:18550579 PMID:25741868 PMID:28492532 More...
|
|
NCBI chrNW_004936557:5,834,874...5,838,502
Ensembl chrNW_004936557:5,834,874...5,838,502
|
|
G |
Il19 |
interleukin 19 |
|
ISO |
ClinVar Annotator: match by term: Cholangiocarcinoma |
ClinVar |
PMID:11121048 PMID:14657422 PMID:14657427 PMID:18550579 PMID:25741868 PMID:28492532 More...
|
|
NCBI chrNW_004936557:5,765,093...5,769,853
Ensembl chrNW_004936557:5,765,093...5,769,853
|
|
G |
Il1b |
interleukin 1 beta |
|
ISO |
ClinVar Annotator: match by term: Cholangiocarcinoma |
ClinVar |
PMID:18550579 |
|
NCBI chrNW_004936783:1,251,678...1,256,807
Ensembl chrNW_004936783:1,252,158...1,257,165
|
|
G |
Il1r2 |
interleukin 1 receptor type 2 |
disease_progression |
ISO |
mRNA:altered expression:liver (human) |
RGD |
PMID:31687280 |
RGD:152998978 |
NCBI chrNW_004936713:679,680...716,801
Ensembl chrNW_004936713:701,155...716,650
|
|
G |
Il4r |
interleukin 4 receptor |
|
ISO |
mRNA:increased expression:bile duct |
RGD |
PMID:18798553 |
RGD:2317263 |
NCBI chrNW_004936501:11,025,590...11,058,807
Ensembl chrNW_004936501:11,025,567...11,058,818
|
|
G |
Il6 |
interleukin 6 |
|
ISO |
ClinVar Annotator: match by term: Cholangiocarcinoma |
ClinVar |
PMID:9769329 PMID:10720087 PMID:11001912 PMID:11889177 PMID:12519862 PMID:12560873 PMID:12719374 PMID:15070960 PMID:15331795 PMID:15472205 PMID:16150725 PMID:16278864 PMID:17623760 PMID:18550579 More...
|
|
NCBI chrNW_004936549:7,015,595...7,016,246
|
|
G |
Ins |
insulin |
disease_progression |
ISO |
mRNA:altered expression:liver (human) |
RGD |
PMID:31687280 |
RGD:152998978 |
NCBI chrNW_004936816:1,002,137...1,003,357
Ensembl chrNW_004936816:1,002,137...1,003,357
|
|
G |
Kcnd2 |
potassium voltage-gated channel subfamily D member 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:34418280 |
|
NCBI chrNW_004936605:4,370,222...4,828,972
Ensembl chrNW_004936605:4,372,671...4,825,423
|
|
G |
Kit |
KIT proto-oncogene, receptor tyrosine kinase |
disease_progression |
ISO |
mRNA:altered expression:liver (human) |
RGD |
PMID:31687280 |
RGD:152998978 |
NCBI chrNW_004936482:17,162,854...17,238,319
Ensembl chrNW_004936482:17,162,950...17,238,274
|
|
G |
Kmt2c |
lysine methyltransferase 2C |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:22561520 |
|
NCBI chrNW_004936527:7,310,885...7,508,032
Ensembl chrNW_004936527:7,312,721...7,506,365
|
|
G |
Kras |
KRAS proto-oncogene, GTPase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:8968066 PMID:22561520 |
|
NCBI chrNW_004936548:2,078,568...2,113,877
Ensembl chrNW_004936548:2,079,036...2,110,523
|
|
G |
Krt7 |
keratin 7 |
|
ISO |
|
RGD |
PMID:18393293 |
RGD:2317308 |
NCBI chrNW_004936512:9,641,587...9,656,573
Ensembl chrNW_004936512:9,641,587...9,656,524
|
|
G |
LOC101957714 |
1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial |
|
ISO |
protein:increased expression:intrahepatic bile, extrahepatic bile duct (human) |
RGD |
PMID:23375797 |
RGD:151361187 |
NCBI chrNW_004936514:1,467,460...1,480,185
Ensembl chrNW_004936514:1,467,261...1,480,185
|
|
G |
LOC101963142 |
mucin-3B |
|
ISO |
mRNA:decreased expression:bile duct |
RGD |
PMID:11680592 |
RGD:2324948 |
NCBI chrNW_004936543:886,333...904,504
|
|
G |
LOC101964975 |
interleukin-8 |
|
ISO |
ClinVar Annotator: match by term: Cholangiocarcinoma |
ClinVar |
PMID:18550579 |
|
NCBI chrNW_004936598:1,779,471...1,781,353
Ensembl chrNW_004936598:1,779,471...1,781,353
|
|
G |
LOC101971027 |
neuroendocrine secretory protein 55 |
disease_progression |
ISO |
DNA:polymorphism:393T>C (human) CTD Direct Evidence: marker/mechanism |
RGD CTD |
PMID:17356712 PMID:22561520 |
RGD:1601377 |
NCBI chrNW_004936530:1,353,432...1,407,437
|
|
G |
Mdm2 |
MDM2 proto-oncogene |
disease_progression |
ISO |
protein:increased expression:intrahepatic bile duct (human) |
RGD |
PMID:15619210 |
RGD:2317417 |
NCBI chrNW_004936545:6,709,903...6,732,334
|
|
G |
Met |
MET proto-oncogene, receptor tyrosine kinase |
disease_progression |
ISO |
protein:increased phosphorylation:liver, carcinoma (human) protein:increased expression:liver, biliary epithelium (rat) |
RGD |
PMID:14656942 PMID:16818635 |
RGD:2317578 RGD:2317601 |
NCBI chrNW_004936589:2,280,803...2,390,179
Ensembl chrNW_004936589:2,280,799...2,390,179
|
|
G |
Mfsd4a |
major facilitator superfamily domain containing 4A |
disease_progression |
ISO |
mRNA:altered expression:liver (human) |
RGD |
PMID:31687280 |
RGD:152998978 |
NCBI chrNW_004936557:6,823,771...6,852,534
Ensembl chrNW_004936557:6,823,597...6,842,741
|
|
G |
Mgmt |
O-6-methylguanine-DNA methyltransferase |
|
ISO |
DNA:hypermethylation:promoter (human) |
RGD |
PMID:17550320 |
RGD:2317632 |
NCBI chrNW_004936486:16,744,607...16,923,209
Ensembl chrNW_004936486:16,744,570...16,923,543
|
|
G |
Mki67 |
marker of proliferation Ki-67 |
disease_progression |
ISO |
|
RGD |
PMID:12903495 |
RGD:2317705 |
NCBI chrNW_004936486:15,561,327...15,587,109
|
|
G |
Mmp2 |
matrix metallopeptidase 2 |
disease_progression |
ISO |
protein:increased expression:bile duct |
RGD |
PMID:15213623 PMID:19629755 |
RGD:2324667 RGD:2325769 |
NCBI chrNW_004936475:7,801,356...7,825,831
Ensembl chrNW_004936475:7,801,277...7,825,851
|
|
G |
Mmp9 |
matrix metallopeptidase 9 |
|
ISO |
protein:increased expression:bile duct mRNA:increased expression:bile duct |
RGD |
PMID:15213623 PMID:16463672 |
RGD:2324667 RGD:2325856 |
NCBI chrNW_004936514:7,038,240...7,045,873
Ensembl chrNW_004936514:7,037,639...7,045,793
|
|
G |
Mthfr |
methylenetetrahydrofolate reductase |
susceptibility |
ISO |
DNA:polymorphism (human) |
RGD |
PMID:17201138 |
RGD:2317119 |
NCBI chrNW_004936474:623,438...637,849
Ensembl chrNW_004936474:623,291...638,193
|
|
G |
Muc1 |
mucin 1, cell surface associated |
disease_progression |
ISO |
protein:increased secretion:bile protein:increased expression:bile duct: protein:increased expression:serum mRNA:increased expression:bile duct |
RGD |
PMID:15213623 PMID:18081149 PMID:19055478 PMID:19260467 PMID:19639217 |
RGD:2317986 RGD:2324622 RGD:2324638 RGD:2324664 RGD:2324667 |
NCBI chrNW_004936580:4,691,870...4,694,092
|
|
G |
Muc16 |
mucin 16, cell surface associated |
|
ISO |
associated with Opisthorchiasis;protein:increased expression:serum |
RGD |
PMID:1653472 |
RGD:2325142 |
NCBI chrNW_004936588:5,506,683...5,586,450
|
|
G |
Muc2 |
mucin 2, oligomeric mucus/gel-forming |
|
ISO |
mRNA:decreased expression:bile duct |
RGD |
PMID:11680592 |
RGD:2324948 |
NCBI chrNW_004936816:60,499...91,628
Ensembl chrNW_004936816:60,499...91,628
|
|
G |
Muc4 |
mucin 4, cell surface associated |
disease_progression |
ISO |
protein:increased expression:bile duct |
RGD |
PMID:14752841 PMID:19082442 |
RGD:2303602 RGD:2324944 |
NCBI chrNW_004936784:515,608...539,915
|
|
G |
Muc5ac |
mucin 5AC, oligomeric mucus/gel-forming |
disease_progression |
ISO |
protein:increased expression:serum mRNA:increased expression:bile duct |
RGD |
PMID:11680592 PMID:14508831 |
RGD:2324948 RGD:2324990 |
NCBI chrNW_004936816:129,926...159,396
|
|
G |
Muc5b |
mucin 5B, oligomeric mucus/gel-forming |
|
ISO |
mRNA:decreased expression:bile duct |
RGD |
PMID:11680592 |
RGD:2324948 |
NCBI chrNW_004936816:174,943...209,241
|
|
G |
Muc6 |
mucin 6, oligomeric mucus/gel-forming |
|
ISO |
protein:increased expression: : |
RGD |
PMID:10209489 |
RGD:2325167 |
NCBI chrNW_004936816:882...14,717
|
|
G |
Ncam1 |
neural cell adhesion molecule 1 |
|
ISO |
associated with hepatitis |
RGD |
PMID:12031086 |
RGD:2326079 |
NCBI chrNW_004936612:1,262,557...1,556,281
Ensembl chrNW_004936612:1,262,544...1,556,016
|
|
G |
Nos2 |
nitric oxide synthase 2 |
|
ISO |
protein:increased expression:bile duct CTD Direct Evidence: marker/mechanism |
RGD CTD |
PMID:16094703 PMID:16818635 |
RGD:2325280 |
NCBI chrNW_004936538:4,052,277...4,097,051
Ensembl chrNW_004936538:4,052,448...4,097,051
|
|
G |
Notch1 |
notch receptor 1 |
|
ISO |
protein:increased expression:cholangiocyte |
RGD |
PMID:15887117 |
RGD:2325330 |
NCBI chrNW_004936669:1,292,016...1,334,061
Ensembl chrNW_004936669:1,292,088...1,332,428
|
|
G |
Nr1h4 |
nuclear receptor subfamily 1 group H member 4 |
disease_progression |
ISO |
mRNA:decreased expression:liver (rat) |
RGD |
PMID:24255171 |
RGD:15090822 |
NCBI chrNW_004936492:13,315,265...13,365,186
Ensembl chrNW_004936492:13,315,265...13,374,034
|
|
G |
Ogg1 |
8-oxoguanine DNA glycosylase |
disease_progression |
ISO |
DNA:loss of heterozygosity (human) |
RGD |
PMID:11260864 PMID:11866974 |
RGD:2317134 RGD:2317136 |
NCBI chrNW_004936602:3,411,106...3,418,826
Ensembl chrNW_004936602:3,413,282...3,418,831
|
|
G |
Osbp2 |
oxysterol binding protein 2 |
|
ISO |
mRNA:increased expression:blood |
RGD |
PMID:21763455 |
RGD:41404644 |
NCBI chrNW_004936755:31,113...120,747
Ensembl chrNW_004936755:31,009...121,887
|
|
G |
Osbpl7 |
oxysterol binding protein like 7 |
|
ISO |
mRNA:increased expression:blood |
RGD |
PMID:21763455 |
RGD:41404644 |
NCBI chrNW_004936490:13,491,704...13,506,742
Ensembl chrNW_004936490:13,491,544...13,506,768
|
|
G |
Panx2 |
pannexin 2 |
disease_progression |
ISO |
mRNA:altered expression:liver (human) |
RGD |
PMID:31687280 |
RGD:152998978 |
NCBI chrNW_004936629:618,758...626,446
Ensembl chrNW_004936629:618,042...626,452
|
|
G |
Pawr |
pro-apoptotic WT1 regulator |
|
ISO |
mRNA,protein:decreased expression:cholangiocyte: |
RGD |
PMID:20724592 |
RGD:9835357 |
NCBI chrNW_004936698:650,225...746,593
Ensembl chrNW_004936698:650,953...747,057
|
|
G |
Pbrm1 |
polybromo 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:24185509 |
|
NCBI chrNW_004936473:3,382,618...3,476,049
Ensembl chrNW_004936473:3,382,260...3,476,052
|
|
G |
Peg3 |
paternally expressed 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:22561520 |
|
NCBI chrNW_004936882:577,424...607,691
Ensembl chrNW_004936882:577,395...591,042
|
|
G |
Pes1 |
pescadillo ribosomal biogenesis factor 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:34845814 |
|
NCBI chrNW_004936904:125,922...140,559
Ensembl chrNW_004936904:126,003...140,235
|
|
G |
Pir |
pirin |
disease_progression |
ISO |
mRNA:altered expression:liver (human) |
RGD |
PMID:31687280 |
RGD:152998978 |
NCBI chrNW_004936470:4,794,803...4,902,211
Ensembl chrNW_004936470:4,793,823...4,902,471
|
|
G |
Ppia |
peptidylprolyl isomerase A |
ameliorates |
ISO |
human cell line and construct in a mouse model |
RGD |
PMID:21871105 |
RGD:150429623 |
NCBI chrNW_004936478:19,669,727...19,673,355
Ensembl chrNW_004936478:19,669,506...19,673,398
|
|
G |
Ppp3ca |
protein phosphatase 3 catalytic subunit alpha |
disease_progression |
ISO |
mRNA:altered expression:liver (human) |
RGD |
PMID:31687280 |
RGD:152998978 |
NCBI chrNW_004936520:1,987,989...2,146,473
Ensembl chrNW_004936520:1,987,045...2,146,540
|
|
G |
Prex2 |
phosphatidylinositol-3,4,5-trisphosphate dependent Rac exchange factor 2 |
sexual_dimorphism |
ISO |
DNA:substitutions, insertion/deletions: (human) |
RGD |
PMID:28000796 |
RGD:151665188 |
NCBI chrNW_004936496:6,005,410...6,284,332
Ensembl chrNW_004936496:6,008,277...6,284,346
|
|
G |
Prkaca |
protein kinase cAMP-activated catalytic subunit alpha |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:26258846 |
|
NCBI chrNW_004936659:2,750,015...2,765,914
Ensembl chrNW_004936659:2,750,537...2,765,753
|
|
G |
Prkacb |
protein kinase cAMP-activated catalytic subunit beta |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:26258846 |
|
NCBI chrNW_004936608:1,353,905...1,464,636
Ensembl chrNW_004936608:1,353,897...1,464,636
|
|
G |
Prrg4 |
proline rich and Gla domain 4 |
disease_progression |
ISO |
mRNA:altered expression:liver (human) |
RGD |
PMID:31687280 |
RGD:152998978 |
NCBI chrNW_004936533:5,032,718...5,053,452
Ensembl chrNW_004936533:5,032,581...5,053,529
|
|
G |
Prss56 |
serine protease 56 |
disease_progression |
ISO |
mRNA:altered expression:liver (human) |
RGD |
PMID:31687280 |
RGD:152998978 |
NCBI chrNW_004936525:4,568,854...4,574,332
Ensembl chrNW_004936525:4,568,802...4,574,396
|
|
G |
Pten |
phosphatase and tensin homolog |
|
ISO |
CTD Direct Evidence: marker/mechanism |
RGD CTD |
PMID:23376645 PMID:27022031 |
RGD:12802341 |
NCBI chrNW_004936735:1,252,414...1,338,318
Ensembl chrNW_004936735:1,252,414...1,338,323
|
|
G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
|
ISO |
ClinVar Annotator: match by term: Cholangiocarcinoma |
ClinVar |
|
|
NCBI chrNW_004936481:3,821,564...3,828,086
|
|
G |
Rassf8 |
Ras association domain family member 8 |
disease_progression |
ISO |
mRNA:altered expression:liver (human) |
RGD |
PMID:31687280 |
RGD:152998978 |
NCBI chrNW_004936548:1,353,237...1,444,176
Ensembl chrNW_004936548:1,352,902...1,444,202
|
|
G |
Reg1a |
regenerating family member 1 alpha |
susceptibility |
ISO |
mRNA, protein:increased expression:liver (human) |
RGD |
PMID:11343228 |
RGD:10044031 |
NCBI chrNW_004936556:4,873,331...4,875,608
Ensembl chrNW_004936556:4,873,331...4,875,608
|
|
G |
Rnf39 |
ring finger protein 39 |
disease_progression |
ISO |
mRNA:altered expression:liver (human) |
RGD |
PMID:31687280 |
RGD:152998978 |
NCBI chrNW_004936723:967,376...972,496
Ensembl chrNW_004936723:967,263...975,952
|
|
G |
Rnf43 |
ring finger protein 43 |
exacerbates |
ISO |
CTD Direct Evidence: marker/mechanism associated with opisthorchiasis;DNA:SNPs:multiple: (human) |
CTD RGD |
PMID:22561520 |
RGD:151361227 |
NCBI chrNW_004936490:4,660,904...4,742,669
Ensembl chrNW_004936490:4,683,725...4,741,828
|
|
G |
Robo2 |
roundabout guidance receptor 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:22561520 |
|
NCBI chrNW_004936505:5,544,011...6,747,417
Ensembl chrNW_004936505:5,548,164...6,094,225
|
|
G |
Runx3 |
RUNX family transcription factor 3 |
|
ISO |
protein:decreased expression:bile duct |
RGD |
PMID:19827872 |
RGD:2324955 |
NCBI chrNW_004936474:9,751,946...9,802,910
Ensembl chrNW_004936474:9,751,946...9,802,910
|
|
G |
Slc4a4 |
solute carrier family 4 member 4 |
disease_progression |
ISO |
mRNA:altered expression:liver (human) |
RGD |
PMID:31687280 |
RGD:152998978 |
NCBI chrNW_004936598:3,391,587...3,713,629
Ensembl chrNW_004936598:3,391,575...3,713,635
|
|
G |
Slc5a5 |
solute carrier family 5 member 5 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:17408651 |
|
NCBI chrNW_004936596:3,176,009...3,188,637
Ensembl chrNW_004936596:3,177,422...3,188,637
|
|
G |
Slc7a5 |
solute carrier family 7 member 5 |
treatment disease_progression |
ISO |
|
RGD |
PMID:24131658 PMID:25475870 PMID:28347255 |
RGD:151361214 RGD:151361287 RGD:151361294 |
NCBI chrNW_004936641:1,513,110...1,538,955
|
|
G |
Smad4 |
SMAD family member 4 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:22561520 |
|
NCBI chrNW_004936497:12,242,869...12,278,012
Ensembl chrNW_004936497:12,249,140...12,278,123
|
|
G |
Socs3 |
suppressor of cytokine signaling 3 |
severity |
ISO |
protein:decreased expression:bile duct (human) |
RGD |
PMID:26485275 |
RGD:11250478 |
NCBI chrNW_004936594:2,932,297...2,935,358
Ensembl chrNW_004936594:2,933,747...2,934,451
|
|
G |
Sox17 |
SRY-box transcription factor 17 |
severity |
ISO |
|
RGD |
PMID:20816680 |
RGD:4889598 |
NCBI chrNW_004936496:1,248,582...1,251,406
Ensembl chrNW_004936496:1,248,577...1,251,430
|
|
G |
Sox2 |
SRY-box transcription factor 2 |
disease_progression |
ISO |
mRNA:altered expression:liver (human) |
RGD |
PMID:31687280 |
RGD:152998978 |
NCBI chrNW_004936566:1,630,698...1,632,607
Ensembl chrNW_004936566:1,631,822...1,632,613
|
|
G |
Tgfb1 |
transforming growth factor beta 1 |
disease_progression |
ISO |
protein:increased expression:pancreas |
RGD |
PMID:12632524 PMID:16083599 |
RGD:1299231 RGD:2325020 |
NCBI chrNW_004936661:3,742,080...3,758,266
Ensembl chrNW_004936661:3,742,066...3,758,272
|
|
G |
Tgfbr2 |
transforming growth factor beta receptor 2 |
|
ISO |
mRNA:increased expression:bile duct |
RGD |
PMID:12632524 |
RGD:1299231 |
NCBI chrNW_004936473:21,324,669...21,409,430
Ensembl chrNW_004936473:21,324,658...21,409,430
|
|
G |
Thbs1 |
thrombospondin 1 |
disease_progression |
ISO |
DNA:hypermethylation (human) |
RGD |
PMID:11927969 PMID:12213730 PMID:16465407 |
RGD:2325024 RGD:2325026 RGD:2325027 |
NCBI chrNW_004936471:3,064,466...3,081,125
Ensembl chrNW_004936471:3,064,422...3,081,949
|
|
G |
Tnc |
tenascin C |
severity |
ISO |
|
RGD |
PMID:20816680 |
RGD:4889598 |
NCBI chrNW_004936487:4,172,263...4,256,780
Ensembl chrNW_004936487:4,172,886...4,233,126
|
|
G |
Tnfaip3 |
TNF alpha induced protein 3 |
severity |
ISO |
protein:increased expression:bile duct (human) |
RGD |
PMID:26485275 |
RGD:11250478 |
NCBI chrNW_004936560:5,124,955...5,138,988
Ensembl chrNW_004936560:5,128,843...5,138,345
|
|
G |
Tp53 |
tumor protein p53 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16818635 PMID:22561520 |
|
NCBI chrNW_004936595:919,807...935,367
Ensembl chrNW_004936595:919,428...925,425
|
|
G |
Ttr |
transthyretin |
|
ISO |
protein:decreased expression:blood serum (human) |
RGD |
PMID:18275060 |
RGD:151660506 |
NCBI chrNW_004936682:1,628,489...1,635,495
Ensembl chrNW_004936682:1,628,341...1,635,566
|
|
G |
Vegfa |
vascular endothelial growth factor A |
|
ISO |
ClinVar Annotator: match by term: Cholangiocarcinoma |
ClinVar |
PMID:18550579 |
|
NCBI chrNW_004936476:16,245,134...16,261,180
Ensembl chrNW_004936476:16,247,100...16,260,673
|
|
G |
Wdhd1 |
WD repeat and HMG-box DNA binding protein 1 |
ameliorates |
ISO |
|
RGD |
PMID:30314946 |
RGD:156420141 |
NCBI chrNW_004936697:129,821...184,238
Ensembl chrNW_004936697:130,105...183,576
|
|
G |
Wnt9a |
Wnt family member 9A |
disease_progression |
ISO |
mRNA:altered expression:liver (human) |
RGD |
PMID:31687280 |
RGD:152998978 |
NCBI chrNW_004936864:216,381...245,885
Ensembl chrNW_004936864:239,651...244,312
|
|
|
G |
Apob |
apolipoprotein B |
|
ISO |
protein:increased expression:serum |
RGD |
PMID:18076041 |
RGD:2325763 |
NCBI chrNW_004936493:10,509,118...10,549,144
Ensembl chrNW_004936493:10,509,118...10,549,144
|
|
G |
Fscn1 |
fascin actin-bundling protein 1 |
|
ISO |
mRNA, protein:increased expression: : |
RGD |
PMID:15136764 |
RGD:2317789 |
NCBI chrNW_004936765:609,894...619,417
Ensembl chrNW_004936765:609,861...619,456
|
|
G |
Mtap |
methylthioadenosine phosphorylase |
|
ISO |
DNA, protein:deletion, decreased expression:common bile duct: |
RGD |
PMID:15662124 |
RGD:2317954 |
NCBI chrNW_004936652:3,431,588...3,468,770
Ensembl chrNW_004936652:3,431,171...3,472,071
|
|
G |
Muc1 |
mucin 1, cell surface associated |
disease_progression |
ISO |
protein:increased expression:bile duct |
RGD |
PMID:8766528 |
RGD:2324856 |
NCBI chrNW_004936580:4,691,870...4,694,092
|
|
G |
Muc4 |
mucin 4, cell surface associated |
|
ISO |
protein:increased expression:pancreas |
RGD |
PMID:8143972 |
RGD:2324890 |
NCBI chrNW_004936784:515,608...539,915
|
|
G |
Muc5ac |
mucin 5AC, oligomeric mucus/gel-forming |
|
ISO |
protein:altered expression:pancreas |
RGD |
PMID:8143972 |
RGD:2324890 |
NCBI chrNW_004936816:129,926...159,396
|
|
G |
Tymp |
thymidine phosphorylase |
disease_progression |
ISO |
|
RGD |
PMID:10760693 |
RGD:2325158 |
NCBI chrNW_004936629:315,609...320,356
Ensembl chrNW_004936629:315,610...319,076
|
|
|
G |
Bap1 |
BRCA1 associated deubiquitinase 1 |
disease_progression |
ISO |
|
RGD |
PMID:25536104 |
RGD:150340631 |
NCBI chrNW_004936473:3,239,009...3,247,806
Ensembl chrNW_004936473:3,239,010...3,247,806
|
|
G |
Pbrm1 |
polybromo 1 |
disease_progression |
ISO |
|
RGD |
PMID:25536104 |
RGD:150340631 |
NCBI chrNW_004936473:3,382,618...3,476,049
Ensembl chrNW_004936473:3,382,260...3,476,052
|
|
G |
Rac1 |
Rac family small GTPase 1 |
|
ISO |
protein:increased expression:mucosa (human) |
RGD |
PMID:21537609 |
RGD:153350126 |
NCBI chrNW_004936750:107,689...122,679
Ensembl chrNW_004936750:107,689...122,676
|
|
G |
Slc7a5 |
solute carrier family 7 member 5 |
disease_progression |
ISO |
|
RGD |
PMID:24890221 |
RGD:151361210 |
NCBI chrNW_004936641:1,513,110...1,538,955
|
|
|
G |
Pkd1 |
polycystin 1, transient receptor potential channel interacting |
|
ISO |
ClinVar Annotator: match by term: Extrahepatic bile duct cancer |
ClinVar |
PMID:25741868 |
|
NCBI chrNW_004936694:1,923,383...1,958,160
Ensembl chrNW_004936694:1,930,621...1,957,179
|
|
G |
Pold1 |
DNA polymerase delta 1, catalytic subunit |
|
ISO |
ClinVar Annotator: match by term: Extrahepatic bile duct cancer |
ClinVar |
PMID:25741868 PMID:26467025 PMID:28492532 |
|
NCBI chrNW_004936889:231,373...250,985
Ensembl chrNW_004936889:231,373...250,987 Ensembl chrNW_004936889:231,373...250,987
|
|
G |
Xpo1 |
exportin 1 |
disease_progression |
ISO |
protein:increased expression:extrahepatic bile duct (human) |
RGD |
PMID:27279267 |
RGD:151665800 |
NCBI chrNW_004936491:6,921,753...6,962,062
Ensembl chrNW_004936491:6,921,319...6,962,343
|
|
|
G |
Apc |
APC regulator of WNT signaling pathway |
|
ISO |
ClinVar Annotator: match by term: Intrahepatic cholangiocarcinoma |
ClinVar |
PMID:24728327 PMID:25479140 PMID:25741868 PMID:26467025 PMID:26530882 PMID:28135048 PMID:28195569 PMID:28492532 PMID:32390703 More...
|
|
NCBI chrNW_004936531:6,899,580...7,019,016
Ensembl chrNW_004936531:6,899,788...7,019,453
|
|
G |
Arid1a |
AT-rich interaction domain 1A |
disease_progression exacerbates |
ISO |
protein:decreased expression:intrahepatic bile duct (human) mRNA,protein:decreased expression:intrahepatic bile duct (human) |
RGD |
PMID:27433094 PMID:30849962 PMID:31665232 |
RGD:126775257 RGD:126781775 RGD:14974231 |
NCBI chrNW_004936474:11,148,857...11,197,312
|
|
G |
Bap1 |
BRCA1 associated deubiquitinase 1 |
disease_progression |
ISO |
|
RGD |
PMID:27864835 |
RGD:150340628 |
NCBI chrNW_004936473:3,239,009...3,247,806
Ensembl chrNW_004936473:3,239,010...3,247,806
|
|
G |
Becn1 |
beclin 1 |
disease_progression |
ISO |
|
RGD |
PMID:30849962 |
RGD:14974231 |
NCBI chrNW_004936490:17,518,100...17,531,126
Ensembl chrNW_004936490:17,517,751...17,531,151
|
|
G |
Braf |
B-Raf proto-oncogene, serine/threonine kinase |
severity |
ISO |
DNA:missense mutation:cds:p.V600E (human) |
RGD |
PMID:24139215 |
RGD:14398746 |
NCBI chrNW_004936592:4,728,371...4,833,830
Ensembl chrNW_004936592:4,737,011...4,834,664
|
|
G |
Fas |
Fas cell surface death receptor |
disease_progression |
ISO |
|
RGD |
PMID:11003620 |
RGD:14700701 |
NCBI chrNW_004936735:209,369...234,582
|
|
G |
Faslg |
Fas ligand |
severity |
ISO |
|
RGD |
PMID:11003620 |
RGD:14700701 |
NCBI chrNW_004936481:14,789,547...14,795,780
|
|
G |
Foxp3 |
forkhead box P3 |
|
ISO |
DNA:hypomethylation:liver |
RGD |
PMID:24291052 |
RGD:38599002 |
NCBI chrNW_004936721:1,118,376...1,125,282
Ensembl chrNW_004936721:1,118,782...1,132,308
|
|
G |
Hsp90aa1 |
heat shock protein 90 alpha family class A member 1 |
disease_progression |
ISO |
protein:increased expression:liver (human) |
RGD |
PMID:24796583 |
RGD:152177907 |
NCBI chrNW_004936835:316,767...321,999
Ensembl chrNW_004936835:316,767...321,990
|
|
G |
Hsp90ab1 |
heat shock protein 90 alpha family class B member 1 |
disease_progression |
ISO |
protein:increased expression:liver (human) |
RGD |
PMID:24796583 |
RGD:152177907 |
NCBI chrNW_004936476:15,830,459...15,836,994
Ensembl chrNW_004936476:15,830,459...15,835,535
|
|
G |
Idh1 |
isocitrate dehydrogenase (NADP(+)) 1 |
no_association |
ISO |
DNA:misssense mutations:cds:p.Arg132Cys,Arg132Leu (human) |
RGD |
PMID:26245674 |
RGD:14974229 |
NCBI chrNW_004936950:334,894...349,221
Ensembl chrNW_004936950:334,934...348,363
|
|
G |
Idh2 |
isocitrate dehydrogenase (NADP(+)) 2 |
disease_progression |
ISO |
DNA:mutations: : mRNA:decreased expression:liver (mouse) |
RGD |
PMID:22824796 PMID:32463951 |
RGD:149735894 RGD:14985256 |
NCBI chrNW_004936483:15,845,777...15,864,341
Ensembl chrNW_004936483:15,845,792...15,864,341
|
|
G |
Kdm5c |
lysine demethylase 5C |
exacerbates |
ISO |
protein:decreased expression:bile duct (human) |
RGD |
PMID:32714863 |
RGD:151361175 |
NCBI chrNW_004936751:159,628...204,136
Ensembl chrNW_004936751:167,920...203,966
|
|
G |
Kras |
KRAS proto-oncogene, GTPase |
disease_progression |
ISO |
DNA:mutations:: |
RGD MouseDO |
PMID:24139215 |
RGD:14398746 |
NCBI chrNW_004936548:2,078,568...2,113,877
Ensembl chrNW_004936548:2,079,036...2,110,523
|
|
G |
Lcn2 |
lipocalin 2 |
treatment |
ISO |
Protein:increased expression:bile duct |
RGD |
PMID:24939880 |
RGD:126790491 |
NCBI chrNW_004936487:15,721,752...15,725,396
Ensembl chrNW_004936487:15,721,684...15,728,221
|
|
G |
LOC101962705 |
membrane-associated guanylate kinase, WW and PDZ domain-containing protein 1 |
disease_progression |
ISO |
protein:increased expression:intrahepatic bile duct (human) |
RGD |
PMID:30377796 |
RGD:152998946 |
NCBI chrNW_004936637:985,706...1,154,670
Ensembl chrNW_004936637:560,298...1,151,850
|
|
G |
Lrp1b |
LDL receptor related protein 1B |
exacerbates |
ISO |
DNA:mutations:multiple: (human) |
RGD |
PMID:33014052 |
RGD:150429786 |
NCBI chrNW_004936469:35,000,773...36,160,216
Ensembl chrNW_004936469:35,203,594...36,159,283
|
|
G |
Pbrm1 |
polybromo 1 |
disease_progression |
ISO |
protein:increased expression:intrahepatic bile duct (human) |
RGD |
PMID:27864835 PMID:30377796 |
RGD:150340628 RGD:152998946 |
NCBI chrNW_004936473:3,382,618...3,476,049
Ensembl chrNW_004936473:3,382,260...3,476,052
|
|
G |
Pten |
phosphatase and tensin homolog |
disease_progression |
ISO |
protein:decreased expression:liver (human) |
RGD |
PMID:24796583 |
RGD:152177907 |
NCBI chrNW_004936735:1,252,414...1,338,318
Ensembl chrNW_004936735:1,252,414...1,338,323
|
|
G |
Rnf43 |
ring finger protein 43 |
exacerbates |
ISO |
mRNA, protein:decreased expression:liver, bile duct epithelium (human) |
RGD |
PMID:26980022 |
RGD:151361125 |
NCBI chrNW_004936490:4,660,904...4,742,669
Ensembl chrNW_004936490:4,683,725...4,741,828
|
|
G |
Smad4 |
SMAD family member 4 |
disease_progression |
ISO |
mRNA,protein:decreased expression:intrahepatic bile duct |
RGD |
PMID:16917866 PMID:23981608 |
RGD:18936999 RGD:21066336 |
NCBI chrNW_004936497:12,242,869...12,278,012
Ensembl chrNW_004936497:12,249,140...12,278,123
|
|
G |
Tep1 |
telomerase associated protein 1 |
|
ISO |
mRNA:increased expression:hepatocyte,biliary epithelium. |
RGD |
PMID:10498642 |
RGD:152977753 |
NCBI chrNW_004936877:575,264...613,965
Ensembl chrNW_004936877:575,037...641,642
|
|
|
G |
Apc |
APC regulator of WNT signaling pathway |
|
ISO |
ClinVar Annotator: match by term: Klatskin tumor |
ClinVar |
PMID:25741868 PMID:28492532 |
|
NCBI chrNW_004936531:6,899,580...7,019,016
Ensembl chrNW_004936531:6,899,788...7,019,453
|
|
G |
Arid1a |
AT-rich interaction domain 1A |
disease_progression |
ISO |
DNA:deletions |
RGD |
PMID:33387086 |
RGD:126848756 |
NCBI chrNW_004936474:11,148,857...11,197,312
|
|
G |
Gata6 |
GATA binding protein 6 |
sexual_dimorphism |
ISO |
DNA:mutations |
RGD |
PMID:33387086 |
RGD:126848756 |
NCBI chrNW_004936550:1,814,336...1,844,399
Ensembl chrNW_004936550:1,814,336...1,844,399
|
|
G |
Kmt2c |
lysine methyltransferase 2C |
onset |
ISO |
DNA:mutations |
RGD |
PMID:33387086 |
RGD:126848756 |
NCBI chrNW_004936527:7,310,885...7,508,032
Ensembl chrNW_004936527:7,312,721...7,506,365
|
|
G |
Kras |
KRAS proto-oncogene, GTPase |
disease_progression |
ISO |
DNA:mutations |
RGD |
PMID:33387086 |
RGD:126848756 |
NCBI chrNW_004936548:2,078,568...2,113,877
Ensembl chrNW_004936548:2,079,036...2,110,523
|
|
G |
Prex2 |
phosphatidylinositol-3,4,5-trisphosphate dependent Rac exchange factor 2 |
sexual_dimorphism |
ISO |
DNA:substitutions, insertion/deletions: (human) |
RGD |
PMID:33387086 |
RGD:126848756 |
NCBI chrNW_004936496:6,005,410...6,284,332
Ensembl chrNW_004936496:6,008,277...6,284,346
|
|